COMMUNIQUÉS West-GlobeNewswire

Neon Therapeutics Reports Second Quarter 2019 Financial Results
06/08/2019
Planning to present more detailed data from NT-001 clinical trial evaluating NEO-PV-01 in advanced or metastatic melanoma, non-small cell lung and bladder cancers at an upcoming medical society meeting Announces U.S. [...]
R1 RCM Reports Second Quarter 2019 Results
06/08/2019
CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
InspireMD Announces Second Quarter 2019 Financial Results
06/08/2019
U.S. Investigational Device Exemption (IDE) application submitted to FDA Company to host investor conference call today, August 6, at 8:00am ET TEL AVIV, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE [...]
Oxford Immunotec Reports Second Quarter 2019 Financial Results
06/08/2019
Second quarter revenue of $19.6 million, an increase of 18% compared to prior year period Gross margin of 72.4%, reflecting our shift towards a pure-play kit business Positive net income of $0.6 million compared to a [...]
Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results
06/08/2019
DOPTELET ® (avatrombopag) approved by U.S. Food and Drug Administration (FDA) for treatment of chronic immune thrombocytopenia (ITP); commercial launch occurred mid-July DOPTELET approved by European Commission (EC) for [...]
Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
06/08/2019
Record Second Quarter Product Revenues of $26.2 Million Represent a 38% Increase Over Second Quarter 2018 Full Year 2019 Revenue Guidance Raised to $112 to $116 Million Conference Call Today at 8:00am Eastern Time [...]
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
06/08/2019
• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/ [...]
Evelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial Results
06/08/2019
-EDP1815 and EDP1066 were Well Tolerated with No Overall Difference Reported from Placebo- -Clinical Response Observed Consistent with Reductions in Cellular Histological and Blood Immune Cell Biomarkers in Psoriasis [...]
Emerald Health Therapeutics Outlines Production and Processing Advancements
06/08/2019
VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives. “With [...]
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial
06/08/2019
The CSV-1000 Diagnostic Instrument is Considered the Standard of Care for the Measurement of Contrast Sensitivity San Diego, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “ [...]
Todos Medical Appoints Dr. Jorge Leon as Medical Advisor
06/08/2019
Dr. Leon previously played a key role in establishing and leading Quest Diagnostics’ Molecular Diagnostics laboratories. REHOVOT, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical- [...]
Rockwell Medical, Inc. Announces Acceptance by FDA of New Drug Application for I.V. TRIFERIC®
06/08/2019
–FDA establishes PDUFA date of March 28, 2020 for I.V. Triferic – WIXOM, Mich., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company [...]
TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires
06/08/2019
Expansion of leadership team to support clinical trials with an emphasis on manufacturing, IND enablement and development of next generation of TRuC-T cells CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR 2 [...]
Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
06/08/2019
DEVON, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference
06/08/2019
SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]
Syneos Health Reports Second Quarter 2019 Results
06/08/2019
Highlights GAAP revenue of $1,166.8 million for the three months ended June 30, 2019, representing growth of 8.8% compared to the same period in 2018. Adjusted revenue of $1,168.4 million for the three months ended June [...]
Digirad Corporation Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2019
06/08/2019
Performed ahead of expectations for revenue, highlighted by Diagnostic Imaging growth of 11% year over year Made significant progress towards “HoldCo” transformation by completing initial filing of registration [...]
Transactions in relation to share buyback program
06/08/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Release date of six-month interim report (Q2) 2019 for ALK and audio cast
06/08/2019
On Tuesday, 13 August 2019, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its six-month interim report (Q2) 2019. ALK will host a meeting for analysts and institutional investors that day at 13.30 p.m. (CEST) at [...]

Pages